These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1400299)

  • 21. Bradykinin regulates the expression of kininogen binding sites on endothelial cells.
    Zini JM; Schmaier AH; Cines DB
    Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence against collagen activation of platelet-associated factor XI as a mechanism for initiating intrinsic clotting.
    Osterud B; Harper E; Rapaport SI; Lavine KK
    Scand J Haematol; 1979 Mar; 22(3):205-13. PubMed ID: 451451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation.
    Baird TR; Walsh PN
    J Biol Chem; 2002 Aug; 277(32):28498-503. PubMed ID: 12029092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.
    Reddigari SR; Kuna P; Miragliotta G; Shibayama Y; Nishikawa K; Kaplan AP
    Blood; 1993 Mar; 81(5):1306-11. PubMed ID: 8443392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 27. The expression of high molecular weight kininogen on human umbilical vein endothelial cells.
    Schmaier AH; Kuo A; Lundberg D; Murray S; Cines DB
    J Biol Chem; 1988 Nov; 263(31):16327-33. PubMed ID: 2460446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.
    Sun MF; Zhao M; Gailani D
    J Biol Chem; 1999 Dec; 274(51):36373-8. PubMed ID: 10593931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen.
    von dem Borne PA; Koppelman SJ; Bouma BN; Meijers JC
    Thromb Haemost; 1994 Sep; 72(3):397-402. PubMed ID: 7855791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
    Baglia FA; Walsh PN
    J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
    Liebman HA; Furie BC; Furie B
    J Biol Chem; 1987 Jun; 262(16):7605-12. PubMed ID: 3108254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of factor XI in plasma is dependent on factor XII.
    Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
    Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of factors IX and IXa to cultured vascular endothelial cells.
    Stern DM; Drillings M; Nossel HL; Hurlet-Jensen A; LaGamma KS; Owen J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4119-23. PubMed ID: 6602986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
    Walsh PN; Sinha D; Kueppers F; Seaman FS; Blankstein KB
    J Clin Invest; 1987 Dec; 80(6):1578-86. PubMed ID: 3500185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium.
    Hasan AA; Cines DB; Ngaiza JR; Jaffe EA; Schmaier AH
    Blood; 1995 Jun; 85(11):3134-43. PubMed ID: 7756645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XI assembly and activation on human umbilical vein endothelial cells in culture.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    Thromb Haemost; 2001 Mar; 85(3):544-51. PubMed ID: 11307829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and chemical synthesis of a substrate-binding site for factor IX on coagulation factor XIa.
    Baglia FA; Jameson BA; Walsh PN
    J Biol Chem; 1991 Dec; 266(35):24190-7. PubMed ID: 1748688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine monoclonal antibodies to human factor XI.
    Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
    Thromb Res; 1986 Apr; 42(2):225-34. PubMed ID: 3487138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.
    DeLa Cadena RA; Colman RW
    Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.